Takaya Takeguchi
Overview
Explore the profile of Takaya Takeguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitsui K, Oda R, Lee T, Watanabe K, Nakamura T, Miyazaki R, et al.
J Infect Chemother
. 2021 May;
27(10):1513-1516.
PMID: 34049794
Mycotic aneurysms are sometimes seen in patients with infective endocarditis. We report a case of infective endocarditis with multiple mycotic aneurysms. Although antibiotics were effective, mycotic aneurysms appeared in the...
2.
Kaneko S, Tsuchiya K, Yasui Y, Inada K, Kirino S, Yamashita K, et al.
JGH Open
. 2020 Dec;
4(6):1183-1190.
PMID: 33319054
Background And Aim: Lenvatinib (LEN) has an antitumor effect with an early reduction in contrast enhancement for unresectable hepatocellular carcinoma (HCC). The aim of this study was to reveal the...
3.
Kaneko S, Tsuchiya K, Yasui Y, Inada K, Kirino S, Yamashita K, et al.
Hepatol Res
. 2020 Sep;
50(12):1375-1385.
PMID: 32924266
Aim: Tyrosine kinase inhibitor (TKI) therapy resulted in better prognosis for patients with hepatocellular carcinoma (HCC). However, some cases with Barcelona Clinic Liver Cancer (BCLC) stage C disease still had...
4.
Kaneko S, Tsuchiya K, Kurosaki M, Kirino S, Inada K, Yamashita K, et al.
Hepatol Res
. 2019 Jul;
50(1):137-143.
PMID: 31349377
Aim: Lenvatinib (LEN) is a newly approved, multikinase inhibitor for treating unresectable hepatocellular carcinoma. In the present study, we investigated the impact of three different criteria for evaluating radiological objective...
5.
Yasui Y, Tsuchiya K, Kurosaki M, Takeguchi T, Takeguchi Y, Okada M, et al.
Hepatol Res
. 2017 Dec;
48(6):442-450.
PMID: 29278654
Aim: Intermediate-stage hepatocellular carcinoma varies widely in tumor burden and liver function. This study aimed to clarify the importance of subclassification by the up-to-seven criteria in both clinical course and...
6.
The vascular anatomy of the ligaments of the liver: gross anatomy, imaging and clinical applications
Ibukuro K, Fukuda H, Tobe K, Akita K, Takeguchi T
Br J Radiol
. 2016 May;
89(1064):20150925.
PMID: 27163944
The vessels that communicate between the liver and adjacent structures require bridges between them. The bridges comprise the ligaments of the liver as follows: the falciform ligament, right and left...
7.
Ibukuro K, Takeguchi T, Fukuda H, Abe S, Tobe K
Surg Radiol Anat
. 2016 Apr;
38(9):1061-1067.
PMID: 27068289
Purpose: To analyze the vascular structure of the liver in patients with a right-sided round ligament. Methods: We reviewed 16 patients with a right-sided round ligament and 3 polysplenia and...
8.
Ibukuro K, Takeguchi T, Fukuda H, Mori M, Abe S, Tobe K
Acta Radiol
. 2014 Sep;
56(9):1091-9.
PMID: 25260419
Background: Although the clinical presentation of intramural hematoma (IMH) and aortic double-lumen dissection (AD) is similar, the imaging results and subsequent clinical course of the two lesions differ. Purpose: To...
9.
Ibukuro K, Takeguchi T, Fukuda H, Abe S, Tobe K, Tagawa K
AJR Am J Roentgenol
. 2013 Apr;
200(5):1160-6.
PMID: 23617505
Objective: The objective of our study was to clarify the hepatic artery anatomy of the left hemiliver using the fusion image of CT angiography (CTA) and CT arterial portography. Materials...
10.
Oshiro Y, Sasaki R, Takeguchi T, Ibukuro K, Ohkohchi N
J Hepatobiliary Pancreat Sci
. 2013 Mar;
20(6):639-46.
PMID: 23475301
Background/purpose: To date there have been only a few radiological studies of the caudate artery. This study aimed to precisely analyze the caudate artery as well as the relationship between...